Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
GameSquare Announces Latest Fortnite UEFN Campaign with Nickelodeon's SpongeBob SquarePants (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Tiziana Life Sciences Ltd TLSA

Healthcare Biotechnology
Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company. The Company develops transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Crohn's Disease and KRAS+ NSCLC. Its pipeline candidates include Foralumab (TZLS-401), Anti IL-6R mAb (TZLS-501) and Milciclib... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:TLSA)

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer's Disease Dosed with Intranasal Foralumab

GlobeNewswire 6 hours ago

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers

GlobeNewswire 13 days ago

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association

GlobeNewswire November 19, 2024

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

GlobeNewswire November 1, 2024

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million

GlobeNewswire October 30, 2024

Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study

GlobeNewswire October 30, 2024

Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer's Disease

GlobeNewswire September 19, 2024

Tiziana Life Sciences Appoints New Chief Executive Officer

GlobeNewswire August 19, 2024

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

GlobeNewswire August 14, 2024
View More News ››

Opinion & Analysis (NDAQ:TLSA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TLSA)

Tiziana Life Sciences Announces Groundbreaking ALS Trial Gra

JUST IN: $TLSA Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS AssociationNEW YORK, Nov. 19, 2024...
whytestocks - November 19, 2024

Tiziana Life Sciences Announces Positive Results from Ozempi

NEWS: $TLSA Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination StudyNEW YORK, Oct. 30, 2024...
whytestocks - October 30, 2024

Tiziana Life Sciences Announces Additional Clinical Improvem

BREAKING NEWS: $TLSA Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded...
whytestocks - April 22, 2024

Tiziana Life Sciences Announces New Quantitative PET Imaging

NEWS: $TLSA Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy...
whytestocks - April 18, 2024
View more Bullboard ››

Anfield Energy Inc

Anfield Energy Inc

Anfield Energy Inc. is a Canada-based uranium and vanadium development and near-term production company. A key asset in the ...
View More »